Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04587271
Other study ID # 58219
Secondary ID K01TW009987-06
Status Completed
Phase N/A
First received
Last updated
Start date July 21, 2021
Est. completion date September 4, 2022

Study information

Verified date October 2023
Source University of Kentucky
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Studies to date on the effects of Moringa oleifera in diabetes and anemia and animal studies that examine the utility of moringa for increased milk and litter yield are of small scale, however high-quality large-scale placebo or case-controlled clinical trials to define the impact on infants of moringa leaf powder consumption by breastfeeding mothers are lacking. Moringa has a traditional and agricultural history of use as a galactagogue; despite this and its incorporation into products such as Mother's Milk Tea© and placement on NIH LactMed Lactation Database, this property has not been studied in large clinical trials nor in populations dependent on breastmilk such as in Kisumu, Kenya. This study will improve and add to existing knowledge of moringa's effect on human breastmilk and will provide novel information on the effect of moringa supplementation to lactating mothers on their infant's intestinal inflammation and health. After trial registration, the study was modified to include infant follow up to 18 months for some measures and the children's groups were removed. Although the study was modified to an 18 month follow up, the data were not able to be collected. Further understanding of the acceptability of moringa leaf in a staple food of porridge and more the effect of moringa supplementation on infant and childhood growth, nutrition, and intestinal and systemic inflammation may translate in the future to the cultivation of moringa at the community or household level as an effective resource for the improvement of childhood undernutrition.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date September 4, 2022
Est. primary completion date September 4, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - lactating women at least 18 years of age and their exclusively breastfed infants within 14 days of delivery. - children 6-59 months of age who eat food Exclusion Criteria: - regular maternal consumption of moringa - receipt and consumption of food supplementation program - inability to feed orally or refusal to eat moringa or placebo porridge - for infants, prematurity (<36 weeks gestational age) - for infants, significant congenital disease - for infants, inability to feed orally

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Moringa oleifera (high dose)
Mothers will receive 20 grams of moringa leaf powder in porridge consumed daily for three months.
Moringa oleifera (low dose)
Children will receive 5-10 grams of moringa leaf powder in porridge consumed daily for three months.
Placebo
Mothers and children will receive porridge with placebo.

Locations

Country Name City State
Kenya Chulaimbo Sub- County Hospital Kisumu
Kenya Kombewa County Hospital Kisumu

Sponsors (2)

Lead Sponsor Collaborator
Suzanna L Attia Fogarty International Center of the National Institute of Health

Country where clinical trial is conducted

Kenya, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Body Weight Body weight at baseline and 3 months
Secondary Change in Infant Height Height (body length) at baseline and 3 months
Secondary Change in Mid-Upper Arm Circumference Mid-upper arm circumference (MUAC) will be measured at baseline and monthly to 3 months. Change from baseline to 3 months reported baseline and 3 months
Secondary Change in Vitamin A Serum retinol binding protein will be used to survey vitamin A levels in infants at baseline and monthly to 3 months.. 3 months
Secondary Change in CRP Levels C-reactive protein (CRP) will be used to measure inflammation at baseline and monthly to 3 months. Change from baseline to 3 months reported. Negative values are considered a better outcome. baseline and 3 months
Secondary Change in the Soluble Transferrin Receptor The soluble transferrin receptor (sTFR) will be used to evaluate anemia at baseline and monthly to 3 months. Change from baseline to 3 months reported. baseline and 3 months
Secondary Change in Fecal Neopterin Fecal neopterin will be measured at baseline and at 3 months. baseline and 3 months
Secondary Change in Fecal Myeloperoxidase Fecal myeloperoxidase will be measured at baseline and at 3 months. baseline and 3 months
Secondary Change in Alpha-1-Antitrypsin Fecal alpha-1-antitrypsin will be measured at baseline and at 3 months. baseline and 3 months
Secondary Change in the Prevalence of Diarrhea Proportion of participants experiencing diarrhea (> 3 watery stools in 24 hours). 1 and 3 months
Secondary Change in Breastmilk Volume Breastmilk volume will be assessed from 24 hour breast pumping or hand expression or weighing the infant before and after feeding for 24 hours. at enrollment and at 3 months
Secondary Change in Breastmilk Vitamin A Levels of vitamin A in breastmilk will be measured at the end of the study. baseline and 3 months
See also
  Status Clinical Trial Phase
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT03268902 - Early Life Interventions for Childhood Growth and Development In Tanzania Phase 2/Phase 3
Active, not recruiting NCT04746664 - Effects of Nutrition Counselling on Old Age People's Nutritional Status and Quality of Life in Bahir Dar City, North West Ethiopia N/A
Completed NCT04608656 - Livestock for Health Project N/A
Completed NCT06009198 - Nutritional, and WASH Related Education Intervention to Address Malnutrition of Early Adolescents in Pakistan N/A
Recruiting NCT05417672 - Assessment of Relationship Between Preoperative Nutritional Status and Perioperative/Postoperative Conditions in Patients With Lung Cancer Scheduled for Lobectomy
Recruiting NCT05257980 - Evaluation of Four New Ready to Drink Oral Nutritional Supplements: Adult ONS Trial N/A
Completed NCT05015647 - Low Protein Diet in CKD Patients at Risk of Malnutrition N/A
Completed NCT03628196 - A Nutrition-Focused QIP in Outpatient Clinics
Enrolling by invitation NCT04675229 - Extending the Validation of SCREEN to Persons Living With Dementia or in Retirement Homes
Recruiting NCT04627376 - Multimodal Program for Cancer Related Cachexia Prevention N/A
Not yet recruiting NCT06047054 - Incidence Rate and Risk Factors of Malnutrition in ICU
Not yet recruiting NCT05860556 - Sustainable Eating Pattern to Limit Malnutrition in Older Adults
Not yet recruiting NCT04398836 - Preoperative Nutrition for Crohn's Disease Patients Phase 3
Not yet recruiting NCT04183075 - Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Patients With Spontaneous Hip Fracture N/A
Not yet recruiting NCT03150927 - Clinical Study of Novel Probiotic Microbial Compositeâ„¢ to Treat Undernourished Young Children N/A
Recruiting NCT02833740 - Comparing Performance of Simplified Mid-Upper Arm Circumference Devices ("Click-MUACs") to Detect Acute Malnutrition N/A
Recruiting NCT03408067 - Evaluation of the Efficacy of Nutritional Risk Screening Tests, NRS 2002 and SGA, to Identifying Malnourished Patients N/A
Completed NCT02938247 - Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Scheduled Intake N/A
Completed NCT02938234 - Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Free Intake N/A